Showing 36,902 results

Filters
Vaccinations & immunisations

NHS England: make sure your clients get flu vaccination

Editor's pick
NHS England
13 November 2014
Cancer

Gay men 'should get anti-cancer jab'

Editor's pick
BBC News
12 November 2014
Exposure to HIV through medical procedures

HIV and hepatitis scare: Dentist named as Desmond D'Mello

Editor's pick
Telegraph
12 November 2014
HIV & criminal law

Consultation: Offences against the Person

Editor's pick
Law Commission
12 November 2014
PrEP

The Case for PrEP, or How I Learned to Stop Worrying and Love HIV-Positive Guys

Editor's pick
The Stranger
12 November 2014
Exposure to HIV through medical procedures

HIV and hepatitis scare: 22,000 patients recalled

Editor's pick
Telegraph
12 November 2014
PrEP

"On Demand" PrEP Reduces Risk of HIV Among Gay Men -- But What About Women?

Editor's pick
The Body Pro
12 November 2014
Epidemiology & behaviour

South Africa: HIV infection highest among men who have sex with men

Editor's pick
Mail & Guardian
11 November 2014
People who inject drugs

More naloxone programmes to prevent the increasing opiate-overdose deaths in England are ungently needed

Editor's pick
International Doctors for Healthier Drug Policies
11 November 2014
Harm reduction

Addiction services in England: in need of an intervention

Editor's pick
The Lancet Psychiatry
10 November 2014
New & experimental hepatitis C treatment

Phase 3 UNITY Trials Demonstrate High Cure Rates for Investigational, All-Oral Daclatasvir TRIO Fixed-Dose Combination in Genotype 1 Hepatitis C Patients, Including Those with Cirrhosis

Editor's pick
Bristol-Myers Squibb press release
10 November 2014
New & experimental hepatitis C treatment

ALLY Trial Demonstrates High Cure Rates for Investigational Daclatasvir and Sofosbuvir Combination among Genotype 3 Hepatitis C Patients

Editor's pick
Bristol-Myers Squibb press release
10 November 2014
New & experimental hepatitis C treatment

Achillion Reports 100% SVR12 in a Phase 2 Combination Study With ACH-3102 at the Liver Meeting 2014 (AASLD)

Editor's pick
Achillion press release
10 November 2014
HIV prevention policy

Time for the UK to get ready for PrEP

Editor's pick
The Lancet HIV
10 November 2014
Combatting stigma

Panic, Paranoia, and Public Health — The AIDS Epidemic's Lessons for Ebola

Editor's pick
New England Journal of Medicine
8 November 2014
PrEP

Rupert Whitaker: A pill for risky sex—another step on the road to a pill for bad housing

Editor's pick
BMJ Group Blogs
8 November 2014
Retention & linkage to care

Study Finds Retention Problems Among South African Patients Receiving HIV Treatment

Editor's pick
Boston University press release
7 November 2014
New & experimental HIV treatments

Innovation in fixed-dose combos: HIV/AIDS therapeutics edition

Editor's pick
BioPharma Dive
7 November 2014
Types of HIV tests

HIV self-test maker to raise £150,000

Editor's pick
Insider Media
7 November 2014
HIV treatment

Viral Load Reductions Persist With Less Efavirenz for HIV

Editor's pick
Medscape (requires free registration)
7 November 2014
Undetectable viral load & treatment as prevention

Is PARTNER Good News Being Ignored?

Editor's pick
Positive Lite
7 November 2014
The search for a cure

Ground-breaking research in Spain may be key to curing HIV

Editor's pick
Think Spain
7 November 2014
Hepatitis C treatment

Olysio (simeprevir) approved for use in combination with sofosbuvir

Editor's pick
Johnson & Johnson press release
7 November 2014
New & experimental HIV treatments

Gilead Submits New Drug Application to U.S. Food and Drug Administration for Tenofovir Alafenamide (TAF)-Based Single Tablet Regimen for HIV

Editor's pick
Gilead press release
7 November 2014